Although beneficial effects of TNF therapies have been observed in patients with RA, Crohn’s disease, SLE, and psoriasis, clinical trials on MS patients showed the opposite effects, with worsening of their symptoms (102). This evidence concerns the gene TNF and rheumatoid arthritis.